Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples